486.98 USD
↘ 5.85 (1.19%)AT CLOSE (11:59 AM EDT)
Madrigal Pharmaceuticals, Inc. Common Stock
MDGLNASDAQ • USD
486.88
↘ 0.10 (0.02%)
POST MARKET (AS OF 05:18 PM EDT)
Post Market
AS OF 05:18 PM EDT
486.88
↘ 0.10 (0.02%)
Market: CLOSED
Open?$494.49
High?$495.18
Low?$481.62
Prev. Close?$492.83
Volume?187.1K
Avg. Volume?278.2K
VWAP?$488.71
Rel. Volume?0.67x
Bid / Ask
Bid?$480.00 × 40
Ask?$495.00 × 40
Spread?$15.00
Midpoint?$487.50
Valuation & Ratios
Market Cap?11.2B
Shares Out?23.1M
Float?16.4M
Float %?71.6%
P/E Ratio?N/A
P/B Ratio?20.66
EPS?-$13.42
Dividend?0.00%
Ex-Dividend?N/A
Madrigal Pharmaceuticals, Inc. Common Stock (MDGL) is currently trading at $486.98. The technical outlook is "Strong Sell" and the fundamental picture shows "Neutral". Notable factors include a robust Altman Z-Score, a weak Piotroski F-Score of 1/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation-wise, the stock is priced at a premium — multiples like P/E and EV/EBITDA sit above sector averages.
Technical & fundamental data as of Jun 5, 2026.
News
Profile
Madrigal Pharmaceuticals Inc is a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH), a serious liver disease with high unmet medical need that can lead to cirrhosis, liver failure, liver cancer, need for liver transplantation and premature mortality. Its medication, Rezdiffra (resmetirom), is a once-daily, oral, liver-directed thyroid hormone receptor beta agonist designed to target key underlying causes of MASH.
Employees
915
Market Cap
11.2B
Industry
PHARMACEUTICAL PREPARATIONS
Website
Listed
2007-02-06
Address
200 BARR HARBOR DRIVE, SUITE 400
WEST CONSHOHOCKEN, PA 19428
Phone: 404-380-9263
WEST CONSHOHOCKEN, PA 19428
Phone: 404-380-9263
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookNeutral
Strong SellNeutralStrong Buy
F-Score?6
Z-Score?100
Momentum?73
Short Sent.?39
Piotroski F-Score?1/9Weak
Altman Z-Score?8.26Safe
Confidence?58%Low
Short InterestSqueeze Risk
Short % of Float?23.72%Squeeze Risk
Short Interest?3.9M
Days to Cover?12.3
Free Float16.4M
Avg Daily Volume316.2K
Settlement Date2026-05-15
Financial Health
Current Ratio?3.48Strong
Quick Ratio?3.15Strong
Cash Ratio?0.67Adequate
Debt/Equity?0.63Moderate
ValuationRICHLY VALUEDvs 1 peers + S&P 500
Score50/100
P/E?N/A▾
P/B?20.66HIGH▾
Peers100
S&P7
P/S?9.91HIGH▾
Peers100
S&P8
P/FCF?N/A▾
EV/EBITDA?-36.4CHEAP▾
S&P97
EV/Sales?10.01HIGH▾
Peers100
S&P11
Returns & Efficiency
ROE?-56.9%WEAK▾
S&P3
ROA?-25.2%WEAK▾
S&P3
Cash Flow & Enterprise
FCF?$-272413000
Enterprise Value?$11.3B
Fundamentals ratios updated end of day